Compare Smith & Nephew plc (SNN) vs Tencent Music Entertainment Group - ADR (TME) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Smith & Nephew plc vs Tencent Music Entertainment Group - ADR — how do they compare? Smith & Nephew plc trades at $27.24 (market cap $11.10B), while Tencent Music Entertainment Group - ADR trades at $8.38 (market cap $12.83B). The key difference: Tencent Music Entertainment Group - ADR is the larger of the two by market cap, and Tencent Music Entertainment Group - ADR pays the higher dividend (3.02%). Which is the better fit depends on your goals — on Pluang, investors hold Smith & Nephew plc for 121 Days and Tencent Music Entertainment Group - ADR for 67 Days on average.
| SNN | TME | |
|---|---|---|
Market Cap | $11.10B | $12.83B |
Volume | 1,051,703 | 3,618,478 |
Sector | Health | Media |
52-Week High | $37.17 | $23.71 |
52-Week Low | $26.42 | $7.74 |
Typical Hold Time | 121 Days | 67 Days |
Enterprise Value | $14.13B | $10.77B |
Dividend Yield | 2.95% | 3.02% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SNN trades at $26.96, up 0.26% on the day, but near its 52-week low amid a bearish technical signal. Recent earnings have mostly beaten expectations, with Q2 2026 EPS of $0.946 exceeding the $0.939 estimate. Revenue grew to $6.16B in 2025, and net income margin improved to 10.08%. The company continues to launch new medical products, such as the EVOS PELVIC System, to drive growth.
The outlook is mixed; strong fundamentals and product innovation support long-term value, but near-term price pressure and analyst caution pose risks. Investors should weigh robust profitability against competitive threats and recent management changes.
Tencent Music Entertainment (TME) trades at $7.96, down 0.38% with bearish technical signals. The company shows strong fundamentals with $32.9B revenue, 33.6% net margin, and attractive valuation ratios (P/E 9.33, P/S 2.46). Recent Q2 2026 earnings beat expectations, but sentiment is mixed amid competitive pressures and slowing growth in some segments.
TME presents a value opportunity with discounted valuation and robust profitability, though facing headwinds from intense competition and user churn. The $12.50 consensus price target suggests 57% upside potential, but investors should monitor execution of the subscription pivot and competitive threats from short-form video platforms.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →About Tencent Music Entertainment Group - ADR
TME is the largest online music service provider in China. It was founded in 2016 with the business combination of QQ Music (founded in 2005), Kuwo Music (founded in 2005) and Kugou Music (founded in 2004) streaming platforms. Tencent is the largest shareholder of TME with over 50% shares and over 90% voting rights held. TME also provides social entertainment services, including music live audio/video broadcasts and online concert services through the three platforms mentioned above, and online karaoke through an independent platform WeSing.
Read more on TME →
